PRO-EPANUTIN Concentrate for solution for infusion Ref.[9267] Active ingredients:

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Pfizer Limited, Sandwich, Kent, CT13 9NJ, United Kingdom Pro-Epanutin is distributed in the UK by Blackstaff Pharmaceuticals Limited.

Product name and form

Pro-Epanutin 75 mg/mL, Concentrate for solution for infusion/Solution for injection.

Pharmaceutical Form

Concentrate for solution for infusion/Solution for injection.

Pro-Epanutin is a clear, colourless to pale yellow, sterile solution buffered with trometamol adjusted to pH 8.6 to 9.0 with hydrochloric acid.

Qualitative and quantitative composition

Fosphenytoin sodium injection is a prodrug intended for parenteral administration; its active metabolite is phenytoin. 1.5 mg of fosphenytoin sodium is equivalent to 1 mg phenytoin sodium, and is referred to as 1 mg phenytoin sodium equivalents (PE). The amount and concentration of fosphenytoin is always expressed in terms of mg PE.

One mL of Pro-Epanutin contains 75 mg of fosphenytoin sodium (equivalent to 50 mg of phenytoin sodium) (see section 4.2).

Pro-Epanutin is available in 10 mL and 2 mL vials.

Each 10 mL vial contains 500 mg PE.

Each 2 mL vial contains 100 mg PE.

For the full list of excipients, see section 6.1.

List of Excipients

Water for injection
Trometamol buffer
Hydrochloric acid (for pH adjustment)

Pack sizes and marketing

5 and 10 mL untreated Type I clear glass vials (containing 2 and 10 mL solution, respectively) with a Fluorotec coated stopper, and an aluminium seal with flip-off cap.

Boxes of 5 vials with 2 mL solution.
Boxes of 10 vials with 2 mL solution.
Boxes of 25 vials with 2 mL solution.
Boxes containing 10 boxes of 5 vials (=50 vials) with 2 mL solution.

Boxes of 5 vials with 10 mL solution.
Boxes of 10 vials with 10 mL solution.
Boxes containing 5 boxes of 5 vials (=25 vials) with 10 mL solution.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Limited, Sandwich, Kent, CT13 9NJ, United Kingdom

Pro-Epanutin is distributed in the UK by Blackstaff Pharmaceuticals Limited.

Marketing authorization dates and numbers

PL 00057/0551

Date of first authorisation: 28th July 2004
Date of latest renewal: 11th September 2009

Drugs

Drug Countries
PRO-EPANUTIN Finland, Ireland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.